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Introduction: Pleural effusion induced by sarcoidosis is rare, and pleural sarcoidosis is often diagnosed by
thoracoscopic surgery. The diagnosis of pleural sarcoidosis using thoracentesis may be less invasive when
sarcoidosis is already diagnosed histologically in more than one organ specimen. Here we report the case of a
64-year-old woman with pleural sarcoidosis diagnosed on the basis of an increased CD4/CD8 lymphocyte ratio in
pleural effusion fluid obtained by thoracentesis. This case report is important because it highlights the usefulness of
the CD4/CD8 lymphocyte ratio in pleural effusion as an indicator of pleural involvement of sarcoidosis.
Case presentation: A 64-year-old Japanese woman visited our hospital with an initial symptom of dyspnea on
exertion for a period of 4 months. Chest computed tomography showed bilateral hilar and multiple mediastinal
lymphadenopathy, multiple small nodular shadows in her bilateral lungs, small nodular shadows along the
interlobar pleura, and bilateral pleural effusion. Her serum angiotensin-converting enzyme and soluble interleukin-2
receptor levels were elevated. Histological analysis of a resected subcutaneous nodule, and biopsy specimens from
a right mediastinal lymph node and from her right lung revealed non-caseous epithelioid granulomas. Her
bronchoalveolar lavage fluid exhibited a predominance of lymphocytes together with an increase in the CD4/CD8
lymphocyte ratio. The lymphocytic predominance and the increased CD4/CD8 lymphocyte ratio were also detected
in the right-sided pleural effusion fluid obtained by thoracentesis. We diagnosed sarcoidosis with pleural
involvement. Because pleural effusion did not resolve spontaneously and her symptom of dyspnea on exertion
worsened, corticosteroid therapy was initiated, which ameliorated the sarcoidosis and the pleuritis.
Conclusions: Analysis of the CD4/CD8 lymphocyte ratio in pleural effusion fluid obtained by thoracentesis may be
helpful for the diagnosis of pleural sarcoidosis when the diagnosis is already made by histological examination of
more than one organ specimen.
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Sarcoidosis is a systemic granulomatous disease of an
unknown cause that may involve the lungs, lymph
nodes, eyes, salivary glands, skin, liver, spleen, heart, ner-
vous system, muscles, bone, and other organs [1]. A clin-
ical diagnosis is made by the histological confirmation of
non-caseous epithelioid granulomas in more than one
organ specimen along with the exclusion of other known* Correspondence: torukumagai@ybb.ne.jp
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90% of cases [1]. Pulmonary sarcoidosis is characterized
by the infiltration of activated T-cells bearing CD4 and
macrophages [1]. When the CD4/CD8 lymphocyte ratio
in bronchoalveolar lavage (BAL) fluid (BALF) is greater
than 3.5, the sensitivity and specificity for the diagnosis of
sarcoidosis are 53% and 94%, respectively, with a positive
predictive value of 76% [1]. Serum soluble interleukin-2
receptor (sIL2R) and serum Krebs von den Lungen-6
(KL6) values are correlated with the number of total cells,
lymphocytes and T-lymphocytes bearing CD4 in BALF,
suggesting that these may reflect alveolitis induced by sar-
coidosis [2]. Sarcoidosis can also involve the pleura:le is distributed under the terms of the Creative Commons Attribution 4.0
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with sarcoidosis [3] and in approximately 3% of all cases
of sarcoidosis [4]. Pleural sarcoidosis is diagnosed clinic-
ally [3, 5, 6] or histologically by thoracoscopy [7, 8] or per-
cutaneous pleural biopsy [3, 9].
Exclusion of tuberculosis and fungal disease is import-
ant for an accurate diagnosis [10]. Thoracoscopy may
not always be required to determine the etiology of
pleural effusion in patients with sarcoidosis when the
diagnosis is already definitive by the histological analysis
of other plural organ specimens. Here we report the case
of a 64-year-old woman in whom analysis of the CD4/
CD8 lymphocyte ratio in pleural effusion fluid obtained
by thoracentesis was helpful for the clinical diagnosis of
pleural sarcoidosis.
Case presentation
A 64-year-old Japanese woman visited our hospital with
an initial symptom of dyspnea on exertion. For the past 4
months she had shortness of breath when she walked
approximately 100 meters or went up 10 to 20 steps of a
staircase. She visited her neighboring hospital 1 month be-
fore visiting our hospital where she received a diagnosis of
bilateral pleural effusions and seven sessions of thoracent-
esis; however, no clinical diagnosis could be made al-
though her dyspnea on exertion was slightly improved by
the frequent thoracentesis. When she visited our hospital
for the first time, she felt dyspnea on exertion on the
ground level after several hundred meters. Before she had
dyspnea on exertion, she had not had any diseases includ-
ing sarcoidosis nor had she received any continuous medi-
cations such as immunosuppressive drugs. She had no
previous history relating pleural effusion, and no family
history of sarcoidosis. She did not have any past history
for opportunistic infections. A chest radiograph showed
the enlargement of bilateral hilar shadows, reticulonodular
shadows in bilateral lung fields, and dullness at the right
costophrenic angle (Fig. 1a). Her serum angiotensin-Fig. 1 Chest radiography. a Before the first admission. b Before the initiatio
corticosteroid therapyconverting enzyme (ACE) level was elevated to 44.2 IU/L.
Her immunoglobulin G (IgG) and sIL2R levels were also
elevated (Table 1). Bacterial culture for sputum resulted in
negative findings for tuberculosis. Polymerase chain reaction
(PCR) analysis also showed no tuberculosis in her sputum.
Three weeks later, she was admitted to our hospital for
diagnosis and treatment. Neither restrictive pulmonary
function disorder nor remarkably reduced diffusing cap-
acity of her lungs was observed. The 6-minute walk test
revealed that she could walk up to 370 meters with a
minimum blood oxygen saturation (spO2) of 93%, max-
imum pulse of 126 beats per minute and the worst modi-
fied Borg scale of perceived dyspnea of 1. Chest computed
tomography (CT) showed multiple skin nodules, bilateral
hilar and mediastinal lymphadenopathy, bilateral pleural
effusion, and multiple small nodules in both lungs and
along the interlobar pleura (Fig. 2a-d). Pulmonary embol-
ism was not observed in chest CT. Multiple subcutaneous
nodules were palpable in her neck, back, and bilateral
arms. Gallium-67 scintigraphy exhibited abnormal uptake
in the right subclavicular area, mediastinum, bilateral
hilum, bilateral parotid glands, and spleen, but no abnor-
mal uptake in her heart, suggesting sarcoidosis or malig-
nant lymphoma (Fig. 3a). A tuberculin test was negative.
A skin biopsy specimen was obtained and bronchoscopy
was performed twice, including endobronchial ultra-
sound-guided transbronchial needle aspiration (EBUS-
TBNA), BAL, and transbronchial lung biopsy. Thoracent-
esis was also performed. Histological analysis of a resected
subcutaneous nodule from her left upper arm exhibited
non-caseous epithelioid granuloma (Fig. 4a). Ziehl–Neelsen
staining and Grocott staining tested negative. Histological
analysis of a right mediastinal lymph node (station 4R)
obtained by EBUS-TBNA also showed a non-caseous epi-
thelioid granuloma; malignant lymphoma was ruled out
(Fig. 4b). The aspiration sample of the lymph node revea-
led negative findings for bacteria including tuberculosis.
In addition, PCR analysis for detection of tuberculosis,n of corticosteroid therapy. c Five weeks after the initiation of
Table 1 Laboratory findings from an earlier visit to another hospital and first admission to our hospital
Hematology Serology Bronchoalveolar lavage analysis
WBC 4470/μl CRP 0.79mg/dl Cell numbers 3.5×105/ml
Neu 60.3% IgG 1893mg/dl Cell fractionation
Lymphocyte 20.7% ACE 44.2IU/L Lymphocyte 33%
Monocyte 10.1% sIL2R 3710U/ml Neutrophil 1%
Eosinophil 4.0% CEA 1.1ng/ml Macrophage 66%
Basophil 1.2% Blood gas analysis CD4/8 13.43
RBC 464×104/μl pH 7.395 Bacterial culture negative
Hb 14.0g/dl PaO2 72.9mmHg Pleural effusion
Ht 41.8% PaCO2 41.3mmHg pH 7.5
Plt 22.4×104/μl HCO3 24.8mmol/L Specific gravity 1.030
Biochemistry Pulmonary function test Rivalta 2+
TP 6.3g/dl VC 1880ml Protein 4.3mg/dl
Alb 3.3g/dl %VC 82.3% Alb 2.3mg/dl
AST 40IU/L FEV1.0 1270ml ADA 50.4IU/L
ALT 29IU/L FEV1.0% 70% CEA 0.8ng/ml
ALP 764U/L PEF 3070mL/second Cell numbers 882/μl
LDH 183IU/L V50 1040mL/second Cell fractionation
Crt 0.65mg/dl V25 400mL/second Lymphocyte 98%
FBS 90mg/dl V50/V25 2.60 Neutrophil 2%
Na 141mEq/L %DLCO 95.4% CD4/8 ratio 5.62
K 4.5mEq/L DLCO/VA 4580mL/minute/mmHg/L PCR negative for tuberculosis
Cl 104mEq/L Bacterial culture negative
Ca 9.2mg/dl
IP 3.6mg/dl
ACE angiotensin-converting enzyme, ADA adenosine deaminase, Alb albumin, ALP alkaline phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase,
Ca calcium, CEA carcinoembryonic antigen, Cl chlorine, CRP C-reactive protein, Crt creatinie, DLCO carbon monoxide diffusion capacity, FBS fasting blood sugar, FEV1.0
forced expiratory volume in 1 second, Hb hemoglobin, HCO3 bicarbonate, Ht hematocrit, IgG immunoglobulin G, IP inorganic phosphorus, LDH lactate dehydrogenase,
Na sodium, Neu neutrophil, PaCO2 partial pressure of carbon dioxide in arterial blood, PaO2 partial pressure of oxygen in arterial blood, PCR, polymerase chain reaction,
PEF peak expiratory flow, Plt platelets, RBC red blood cell, sIL2R soluble interleukin-2 receptor, TP total protein, V50 and 25 expirtatory flow at 50% and 25% of vital
capacity, respectively, VA alveolar volume, VC vital capacity, WBC white blood cell
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were negative. Bronchofiberscopy revealed multiple small
nodules in both the main bronchi (Fig. 3b), and histological
analysis of an endobronchial nodule and a transbron-
chial lung biopsy specimen from the right upper lobe
revealed non-caseous epithelioid granulomas (Fig. 4c
and d, respectively). The transbronchial lung biopsy
specimen also showed negative Ziehl–Neelsen and Gro-
cott staining. BALF obtained from the right middle lobe
exhibited an increased number of lymphocytes and an
increased CD4/CD8 lymphocyte ratio of 13.43 (Table 1).
Bacterial culture, including that of Mycobacteria, was
negative. On the basis of these findings, a final diagno-
sis of sarcoidosis was made.
Thoracentesis on the right side revealed exudative pleural
effusion fluid. Cell fractionation of the fluid showed the
predominance of lymphocytes without any malignant cells
and an increase in the CD4/CD8 lymphocyte ratio to 5.62(Table 1). Her adenosine deaminase (ADA) level in her
right pleural effusion was 50.4IU/L. However, bacterial
culture including that for Mycobacteria was negative and
PCR analyses for detection of tuberculosis, Mycobacterium
avium and Mycobacterium intracellulare were negative.
Examinations of fundus, electrocardiography and echocar-
diogram revealed no abnormality. Collectively her lungs,
skin, pleura, and, possibly, the parotid glands and spleen
were involved in sarcoidosis.
She was discharged 5 weeks after the first visit and was
followed up for the spontaneous resolution of the bilateral
pleural effusion. However, no improvement was observed
and pleural effusion increased (Fig. 1b). The 6-minute
walk test revealed that she could walk up to 315 meters
with a minimum spO2 of 90%, maximum pulse of 116
beats per minute and the worst modified Borg scale of
perceived dyspnea of 4. In addition, her initial symptom,
which was induced by walking approximately 100 meters
Fig. 2 Chest computed tomography findings on admission. a and b: Multiple mediastinal and bilateral hilar lymphadenopathy, bilateral pleural
effusion, and multiple small subcutaneous nodules indicated by arrows. c and d: Bilateral multiple small nodular shadows in the lungs and
multiple small nodules along the interlobar pleura (arrow)
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vere and was partially improved by frequent thoracentesis.
Based on these findings, corticosteroid therapy with a
daily dose of 30mg prednisolone was initiated 8 weeks
after the first visit. Thirteen weeks later (5 weeks from the
initiation of corticosteroid therapy), under a daily dosageFig. 3 Gallium-67 scintigraphy and bronchoscopic examination. a Gallium-
mediastinum, bilateral hilum, bilateral parotid glands and spleen but no ab
multiple small nodules on the surface of the bilateral bronchi (arrows). A caof 25mg of prednisolone, a chest radiograph showed de-
creased pleural effusion (Fig. 1c), and CT revealed regres-
sion of multiple skin nodules, mediastinal and bilateral
hilar lymphadenopathy, multiple small nodules in her
lungs and the interlobar pleura, bilateral pleural effusion,
and splenomegaly (Fig. 5a-d). The clinical course of67 scintigraphy exhibits abnormal uptake in the right subclavicular area,
normal uptake in the heart. b A bronchoscopic examination reveals
rina is located at the center
Fig. 4 Histological analysis. All pictures are obtained at 20× magnification. a Hematoxylin and eosin staining of a subcutaneous nodule specimen.
b Hematoxylin and eosin staining of a right mediastinal lymph node specimen. c Hematoxylin and eosin staining of an endobronchial nodule
specimen. d Hematoxylin and eosin staining of a transbronchial lung biopsy specimen
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coidosis. Three years later, she received 2.5mg of prednis-
olone per week without any severe adverse events; a chest
CT showed only reduced small nodules in her lungs,
lymphadenopathy, and subcutaneous nodules and no
pleural effusion.Fig. 5 Chest computed tomography findings after 5 weeks of corticosteroi
lymphadenopathy, bilateral pleural effusion, small nodules in the lung andDiscussion
Pleural sarcoidosis is believed to be rare. Huggins et al.
reported that 2.8% of out-patients showed pleural effu-
sion, although a histological diagnosis was made only in
1.1% [3]. In several reported cases, pleural sarcoidosis is
histologically diagnosed by thoracoscopic surgery [7, 8].d therapy. a-d The multiple mediastinal and bilateral hilar
the interlobar pleura, and small subcutaneous nodules have regressed
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[3, 9], it is not always helpful for diagnosing pleural sar-
coidosis [11]. In our case, biopsy specimens obtained from
three organs, namely the skin, lymph nodes and lungs, all
exhibited non-caseous epithelioid granulomas, thus sup-
porting a diagnosis of sarcoidosis. However, the ADA level
in the right pleural effusion was elevated in our case. It
seemed to be difficult to conclude that the high level of
ADA was due to pleural sarcoidosis before treatment. The
ADA level in pleural effusion is well known to be elevated
by tuberculosis [12]. When the ADA level in pleural effu-
sion is cut off at 40IU/L, then all of pleural tuberculosis
exceeded 40IU/L, while 2.5% of non-tuberculosis disease
exceeded 40IU/L. ADA levels of two cases of sarcoidosis
included in the non-tuberculosis group were less than
40IU/L [12]. We thought that tuberculosis should be care-
fully ruled out. The histological analyses by Ziehl–Neelsen
staining, the Mycobacterium cultures, and PCR analyses
did not support tuberculosis. Fungal infection was also
ruled out by histological examination and bacterial culture
of both BALF and pleural effusion fluid. We thought that
thoracoscopy was too invasive for the patient as we
regarded this case met the diagnosis criteria of sarcoidosis.
We also excluded malignant lymphoma by histological
examination of a EBUS-TBNA specimen because her
serum sIL2R level was elevated at the first visit. sIL2R is
not only a marker of malignant lymphoma but is also ele-
vated when a T-cell is activated [13]. Miyoshi et al. re-
ported the elevation of sIL2R in sarcoidosis with active
alveolitis [2]. We finally diagnosed pleural sarcoidosis on
the basis of the identification of small nodules along the
interlobar pleura, lymphocytic predominance, and an in-
creased CD4/CD8 lymphocyte ratio in pleural effusion
fluid. The CD4/CD8 lymphocyte ratio in pleural effusion
induced by tuberculosis is reported to be 3.1±1.1 (mean ±
standard deviation) [14]. The CD4/CD8 lymphocyte ratio
of the right pleural effusion in our case showed 5.62,
which was higher than the ratio of mean +2 standard
deviation value of pleural tuberculosis reported by
Aguiar et al. [14]. Corticosteroid therapy resulted in re-
gression of both small nodules along the interlobar pleura
and bilateral pleural effusion, consistent with the findings
in pleural sarcoidosis. We have carefully followed up for
more than 3 years after the initiation of corticosteroid
therapy. Bilateral pleural effusions disappeared and have
not increased. We regard that tuberculosis and fungal in-
fection were completely excluded. Therefore we con-
cluded that this was a case of pleural sarcoidosis with the
elevation of CD4/CD8 lymphocyte ratio in pleural effu-
sion. The increased CD4/CD8 lymphocyte ratios in BALF
and pleural effusion fluid suggested that T-lymphocytes
bearing CD4 are activated not only in the lungs but also in
the pleura, which may be helpful for diagnosis of pleural
sarcoidosis. When patients with sarcoidosis and pleuraleffusions are already diagnosed histologically in plural
organ specimens, the increased CD4/CD8 lymphocyte ra-
tio in pleural effusion fluid obtained by thoracentesis may
be a minimally invasive substitute for thoracoscopic sur-
gery for the diagnosis of pleural sarcoidosis.
Pleural involvement of sarcoidosis is considered to be
an indication for corticosteroid therapy in recurrent or
symptomatic cases [10, 11]. Asymptomatic pleural effu-
sion may resolve spontaneously [10]. The effects of cor-
ticosteroids for pleural sarcoidosis were satisfactory in
our case. This clinical course supports the findings in a
previous report that pleural sarcoidosis is susceptible to
corticosteroid therapy [11].
Conclusions
In conclusion, we report a case in which pleural sarcoid-
osis was diagnosed on the basis of lymphocytic predom-
inance and an increased CD4/CD8 lymphocyte ratio in
pleural effusion fluid obtained by thoracentesis. This
technique may be useful for the diagnosis of pleural sar-
coidosis when sarcoidosis is already diagnosed histologi-
cally in biopsy specimens from more than one organ.
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